The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
37
No.
45
December 09, 2011
CCL
Vol.
34
No.
12
December 30, 2011
- Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis
- Perifosine Increases PFS In Phase II Study
- Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time
- Carfilzomib Demonstrates Clinical Benefit Rate of 64%
- Single-Letter Mutation Found Responsible For Waldenstrom’s
- New Methods Uncover 1,800 RNAs Linked To Breast Cancer
- Gene Expression Analyses Can Guide MDS Treatments
- Analysis Reveals Patient Subset With Lower PFS in Phase III Trial
- Interim Results Show Vaccine Lowers Breast Cancer Recurrence
- CTCs Do Not Affect Survival, But Could Signal Metastases
- Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects
- Trials Approved by NCI CTEP For the Month of December
- FDA Grants Orphan Designation To Photofrin for Mesothelioma